CAPLIN POINT LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of CAPLIN POINT LABORATORIES have increased by 19.61% YoY .
The Earnings Per Share (EPS) of CAPLIN POINT LABORATORIES has increased by 25.30 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
CAPLIN POINT LABORATORIES Last 5 Annual Financial Results
[BOM: 524742|NSE : CAPLIPOINT]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹1,269 Cr | ₹1,061 Cr | ₹86,320 Cr | ₹649 Cr | ₹540 Cr |
| Expenses | ₹875 Cr | ₹737 Cr | ₹60,313 Cr | ₹417 Cr | ₹345 Cr |
| Operating Profit (Excl OI) | ₹395 Cr | ₹324 Cr | ₹26,007 Cr | ₹232 Cr | ₹195 Cr |
| Other Income | ₹39 Cr | ₹28 Cr | ₹4,133 Cr | ₹19 Cr | ₹13 Cr |
| Interest | ₹0.70 Cr | ₹1.59 Cr | ₹32 Cr | ₹0.58 Cr | ₹0.61 Cr |
| Depreciation | ₹47 Cr | ₹37 Cr | ₹3,162 Cr | ₹23 Cr | ₹19 Cr |
| Profit Before Tax | ₹386 Cr | ₹314 Cr | ₹26,946 Cr | ₹227 Cr | ₹188 Cr |
| Profit After Tax | ₹308 Cr | ₹251 Cr | ₹21,508 Cr | ₹177 Cr | ₹145 Cr |
| Consolidated Net Profit | ₹300 Cr | ₹242 Cr | ₹21,501 Cr | ₹177 Cr | ₹145 Cr |
| Earnings Per Share (Rs) | ₹49.57 | ₹39.56 | ₹32.03 | ₹28.42 | ₹23.34 |
| PAT Margin (%) | 25.70 | 24.30 | 23.69 | 24.92 | 27.22 |
| ROE(%) | 23.68 | 24.77 | 25.65 | 29.58 | 37.14 |
| ROCE(%) | 26.85 | 28.77 | 28.82 | 33.35 | 45.59 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.01 | 0.04 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 10,111.8 Cr |
| Revenue (TTM) | : | ₹ 1,630.2 Cr |
| Net Profit(TTM) | : | ₹ 441.1 Cr |
| EPS (TTM) | : | ₹ 58.1 |
| P/E (TTM) | : | 22.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| CAPLIN POINT LABORATORIES | -1.5% | -16.1% | 106.3% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
CAPLIN POINT LABORATORIES Revenues
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 19.61 % |
| 5 Yr CAGR | 23.83 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹1,269 Cr | 19.61 | |
| Mar2022 | ₹1,061 Cr | -98.77 | |
| Mar2021 | ₹86,320 Cr | 13,206.82 | |
| Mar2020 | ₹649 Cr | 20.16 | |
| Mar2019 | ₹540 Cr | - | |
CAPLIN POINT LABORATORIES Operating Profit
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 21.67 % |
| 5 Yr CAGR | 19.22 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹395 Cr | 21.67 | |
| Mar2022 | ₹324 Cr | -98.75 | |
| Mar2021 | ₹26,007 Cr | 11,116.87 | |
| Mar2020 | ₹232 Cr | 18.71 | |
| Mar2019 | ₹195 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 1.73 % |
| 5 Yr CAGR | -3.73 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 31.08% | 1.73 | |
| Mar2022 | 30.55% | 1.39 | |
| Mar2021 | 30.13% | -15.70 | |
| Mar2020 | 35.74% | -1.22 | |
| Mar2019 | 36.18% | - | |
CAPLIN POINT LABORATORIES Profit After Tax
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 23.76 % |
| 5 Yr CAGR | 19.96 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹300 Cr | 23.76 | |
| Mar2022 | ₹242 Cr | -98.87 | |
| Mar2021 | ₹21,501 Cr | 12,077.96 | |
| Mar2020 | ₹177 Cr | 21.94 | |
| Mar2019 | ₹145 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 5.76 % |
| 5 Yr CAGR | -1.43 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 25.7 % | 5.76 | |
| Mar2022 | 24.3 % | 2.57 | |
| Mar2021 | 23.69 % | -4.94 | |
| Mar2020 | 24.92 % | -8.45 | |
| Mar2019 | 27.22 % | - | |
CAPLIN POINT LABORATORIES Earnings Per Share (EPS)
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 25.30 % |
| 5 Yr CAGR | 20.72 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹50 | 25.30 | |
| Mar2022 | ₹40 | 23.51 | |
| Mar2021 | ₹32 | 12.70 | |
| Mar2020 | ₹28 | 21.77 | |
| Mar2019 | ₹23 | - | |
CAPLIN POINT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | -6.67 % |
| 5 Yr CAGR | -12.40 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 26.85% | -6.67 | |
| Mar2022 | 28.77% | -0.17 | |
| Mar2021 | 28.82% | -13.58 | |
| Mar2020 | 33.35% | -26.85 | |
| Mar2019 | 45.59% | - | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹1,332.3 |
| Current MarketCap | : | ₹ 10,111.8 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | -1.5% |
-16.1% |
106.3% |
| SENSEX | 1.3% |
2.6% |
24% |
CAPLIN POINT LABORATORIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
| S&P BSE 250 SMALLCAP | 2.5% | 12.8% | 64.9% |
| S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
| S&P BSE 400 MIDSMALLCAP | 1.9% | 9.9% | 59.4% |
| S&P BSE ALLCAP | 1.6% | 6% | 40.6% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 | 2.8% | 13.8% | 71.1% |
| NIFTY MID SMALL400 | 2.1% | 10.7% | 62.3% |
| NIFTY500 MULTICAP 50:25:25 | 1.8% | 7.7% | 48.1% |
| NIFTY 500 | 1.5% | 5.7% | 39.5% |
You may also like the below Video Courses
FAQ about CAPLIN POINT LABORATORIES Financials
How the annual revenues of CAPLIN POINT LABORATORIES have changed ?
The Revenues of CAPLIN POINT LABORATORIES have increased by 19.61% YoY .
How the Earnings per Share (EPS) of CAPLIN POINT LABORATORIES have changed?
The Earnings Per Share (EPS) of CAPLIN POINT LABORATORIES has increased by 25.30 % YoY .
Check out Intrinsic Value of Peers of CAPLIN POINT LABORATORIES
Compare Stock Analytics of Peers of CAPLIN POINT LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
